Avalon Investment & Advisory’s DermTech, Inc. Common Stock DMTK Stock Holding History

Avalon Investment & Advisory’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-369,504	Closed	-$1.46M	–	328
2022 Q3	$1.46M	Buy	369,504 +95,154	+35%	+$585K	0.05%	178
2022 Q2	$1.52M	Buy	+274,350	New	+$2.25M	0.04%	178
2021 Q4	–	Sell	-74,568	Closed	-$2.39M	–	350
2021 Q3	$2.39M	Buy	74,568 +1,842	+3%	+$64.7K	0.06%	183
2021 Q2	$3.02M	Buy	+72,726	New	+$2.99M	0.07%	172

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Avalon Investment & Advisory's DMTK Position: Q4 2022 in Review

Avalon Investment & Advisory sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 369,504 shares — an estimated $1.46M sold.

Avalon Investment & Advisory first reported a position in DMTK in Q2 2021 and held it in 4 quarters. The position peaked at $3.02M in Q2 2021. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

Avalon Investment & Advisory reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Avalon Investment & Advisory sold 369,504 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $1.46M.
Avalon Investment & Advisory first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Avalon Investment & Advisory's DermTech, Inc. Common Stock position peaked at $3.02M in Q2 2021.
94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Avalon Investment & Advisory's 13F filing for Q4 2022, filed 13 Feb 2023.